Products & Services · Revenue, remaining performance obligation, amount

Consumables — Revenue, remaining performance obligation, amount

Becton, Dickinson and Company Consumables — Revenue, remaining performance obligation, amount decreased by 16.7% to $2.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $2.20B to $2.00B. Over 4 years (FY 2021 to FY 2025), Consumables — Revenue, remaining performance obligation, amount shows a downward trend with a -4.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2026

How to read this metric

An increase suggests a growing backlog of committed sales and stronger future revenue visibility, while a decrease may indicate faster fulfillment rates or softening demand for future consumable deliveries.

Detailed definition

This metric represents the total transaction price allocated to performance obligations that are unsatisfied or partiall...

Peer comparison

Peers in the medical device and life sciences sector often report this as 'Backlog' or 'Deferred Revenue' related to long-term supply agreements, though specific disclosure levels vary by contract structure.

Metric ID: bdx_segment_consumables_revenue_remaining_performance_obligation_amount

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.80B$2.50B$2.40B$2.40B$2.10B$1.90B$1.90B$2.20B$2.10B$2.00B$2.20B$2.10B$2.10B$2.10B$2.00B$2.20B$2.30B$2.30B$2.40B$2.00B
QoQ Change-10.7%-4.0%+0.0%-12.5%-9.5%+0.0%+15.8%-4.5%-4.8%+10.0%-4.5%+0.0%+0.0%-4.8%+10.0%+4.5%+0.0%+4.3%-16.7%
YoY Change-25.0%-24.0%-20.8%-8.3%+0.0%+5.3%+15.8%-4.5%+0.0%+5.0%-9.1%+4.8%+9.5%+9.5%+20.0%-9.1%
Range$1.90B$2.80B
CAGR-6.8%
Avg YoY Growth-1.9%
Median YoY Growth+0.0%

Frequently Asked Questions

What is Becton, Dickinson and Company's consumables — revenue, remaining performance obligation, amount?
Becton, Dickinson and Company (BDX) reported consumables — revenue, remaining performance obligation, amount of $2.00B in Q1 2026.
How has Becton, Dickinson and Company's consumables — revenue, remaining performance obligation, amount changed year-over-year?
Becton, Dickinson and Company's consumables — revenue, remaining performance obligation, amount decreased by 9.1% year-over-year, from $2.20B to $2.00B.
What is the long-term trend for Becton, Dickinson and Company's consumables — revenue, remaining performance obligation, amount?
Over 4 years (2021 to 2025), Becton, Dickinson and Company's consumables — revenue, remaining performance obligation, amount has grown at a -4.5% compound annual growth rate (CAGR), from $10.60B to $8.80B.
What does consumables — revenue, remaining performance obligation, amount mean?
The total value of contracted but unfulfilled orders for medical consumable products.